Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiency.

MLA

Michaux, Katell, et al. “Eculizumab in Neonatal Hemolytic Uremic Syndrome with Homozygous Factor H Deficiency.” Pediatric Nephrology (Berlin, Germany), vol. 29, no. 12, Dec. 2014, pp. 2415–19. EBSCOhost, https://doi.org/10.1007/s00467-014-2933-1.

APA

Michaux, K., Bacchetta, J., Javouhey, E., Cochat, P., Frémaux-Bacchi, V., & Sellier-Leclerc, A.-L. (2014). Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiency. Pediatric Nephrology (Berlin, Germany), 29(12), 2415–2419. https://doi.org/10.1007/s00467-014-2933-1

Chicago

Michaux, Katell, Justine Bacchetta, Etienne Javouhey, Pierre Cochat, Véronique Frémaux-Bacchi, and Anne-Laure Sellier-Leclerc. 2014. “Eculizumab in Neonatal Hemolytic Uremic Syndrome with Homozygous Factor H Deficiency.” Pediatric Nephrology (Berlin, Germany) 29 (12): 2415–19. doi:10.1007/s00467-014-2933-1.